pre-IPO PHARMA

COMPANY OVERVIEW

Rebiotix Inc. is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome.


LOCATION

  • Roseville, MN, USA

  • THERAPEUTIC AREAS

  • Infectious Disease
  • Inflammatory Disease

  • WEBSITE

    https://www.rebiotix.com


    CAREER WEBSITE

    https://www.rebiotix.com/about-rebiotix/careers-and-employment/


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Aug 21, 2019

    Rebiotix, Inc and Karolinska Institutet Expand Partnership to Shape the Future of Microbiome Research


    Jun 26, 2019

    Rebiotix Leaders to Discuss Microbiome Product Development Challenges and Regulation at Microbiome Movement – Drug Development Summit 2019


    Jan 22, 2019

    Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments


    Nov 1, 2018

    Rebiotix, C. Diff Foundation Commend State of Minnesota for Declaring November Clostridium difficile Awareness Month


    Oct 22, 2018

    Rebiotix Microbiome Health Index™ Data to be Presented at United European Gastroenterology Annual Conference


    For More Press Releases


    Google Analytics Alternative